Assenfali n sskeṛ yemgarad ɣef leḥsab n ṣṣenf n sskeṛ d wamek yettwaḍḍef.
Aṭṭan n sskeṛ n ṣṣenf 1 d aṭṭan n yiman anda tafekka ur d-tettfaras ara tisent, dɣa yeḥwaǧ adawi n tisent i lebda.
S usefrek iwulmen, gar-asent tissegnit n insulin, učči yelhan, akked waddal azayez, imdanen yuḍnen s sskeṛ n ṣṣenf 1 zemren ad idiren aṭas yerna s ṣṣeḥḥa.
D acu kan, ma ur yettwaḍmen ara akken ilaq, yezmer ad d-yawi uguren am aṭṭanen n wul, aṭṭanen n tgeẓẓal, axessar n yiẓuran, d wuguren n wallen.
Aṭṭan n sskeṛ n ṣṣenf wis 2 yettmagga-d s temḥaddit n insulin yerna yettwassaɣ s waṭas d yimgan n tudert am tuget n lmizan d lexṣaṣ n tigawt tafekkawt.
S usefrek iwulmen, gar-asen ddwa, učči d waddal, imdanen yuḍnen sskeṛ n ṣṣenf wis 2 zemren ad swenneεen akayad n ssekker deg idammen-nsen u ad ssneqsen amihi n wuguren.
Deg kra n tegnatin, yezmer ad yeḥlu ssebba n sskeṛ n ṣṣenf wis 2 s usneqseḥ ameqqran n taẓayt d ubeddel n wamek yettidir umdan.
Aṭṭan n sskeṛ n tadist yettili-d deg tadist yerna yettnejmaɛ s umata deffir tarrawt.
D acu kan, tilawin yuḍnen sskeṛ n tadist sɛant amihi meqqren n waṭṭan n sskeṛ n ṣṣenf wis 2 ɣer zdat deg tudert-nsent.
S umata, afares n sskeṛ yelha ma yettwaḍmen akken ilaq, maca yelha ad txedmeḍ s lemḥadra akked terbaεt n udawi akken ad tεasseḍ agerdas n sskeṛ deg idammen u ad tgeḍ ibeddilen n tudert ilaqen i wakken ad tḥebseḍ uguren.
Zhao XB, Ren GS: Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2016, 95 (49): e5602.
Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology. 1998, 27 (6): 1567-71.
Pallisgaard JL, Lindhardt TB, Olesen JB, Hansen ML, Carlson N, Gislason GH: Management and prognosis of atrial fibrillation in the diabetic patient. Expert Rev Cardiovasc Ther. 2015, 13 (6): 643-51.
Borch-Johnsen K: [Insulin-dependent diabetes mellitus--improved prognosis and insurance outlook]. Nord Med. 1992, 107 (8-9): 217-9.
Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Tanikawa M, Sone Y, Hisanaga Y: Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer. 2001, 91 (5): 957-63.
Gao RZ, Gu J, Du CZ, Li M: [Impact of diabetes mellitus on clinicopathological factors and prognosis of patients with colorectal cancer.]. Zhonghua Wai Ke Za Zhi. 2010, 48 (2): 88-92.
['Anfafad: amejjay']
['Asmel-a web yettunefk-d kan i yiswiyen n uselmed d usissen, ur d-yettak ara iwellihen imejjayen neɣ isefka udmawanen.']
['Isallen i d-yettunefken ur ilaq ara ad ttwasqedcen i usebded neɣ i usemḥi n kra n wugur n tezmert neɣ aṭṭan, yerna wid yettnadin ɣef yiwellihen imsujjiyen udmawanen yessefk ad ẓren amejjay yesɛan turagt.']
['Ttxil-k ẓer belli azeṭṭa amseddayan i d-yettaken tiririyin i tuttriwin, ur iṣeḥḥa ara mliḥ ma yella d ayen yerzan uḍḍun. D amedya, amḍan n yimdanen yettwaḍḍfen s kra n waṭṭan.']
['Ssutur dima ṛṛay n ṭṭbib-ik neɣ n kra n umejjay-nniḍen ara iwalmen ɣef waṭṭan-ik. Ɣur-k ad tḥeqreḍ ṛṛay n ṭṭbib amsadur neɣ ad tεeṭṭleḍ deg usuter-is ɣef lǧal n kra i teɣriḍ deg usmel-a. Ma tɣileḍ ahat tesεiḍ liḥala n tεeǧlanit deg tezmert, siwel 911 neɣ ṛuḥ ɣer texxamt n tεeǧlanit i d-iqerben. Ulac assaɣ gar ṭṭbib d umuḍin i d-yettnulfun s usmel-a neɣ aseqdec-is. BioMedLib neɣ ixeddamen-is, neɣ kra n win yettekkiyen deg usmel-a, ur d-ttaken ara yakk kra n yisumren, s wawal neɣ s usemres, ɣef ayen yerzan isallen i d-yettunefken dagi neɣ aseqdec-is.']
['Anekcum: azref n uḍfar']
['Asaḍuf n umeskar n yizerfan n wemdan n alfin (Digital Millennium Copyright Act) n 1998, 17 U.S.C. § 512 (DMCA) yettak-d ttawil i yimeskaren n yizerfan n wemdan i yumnen belli ayen i d-yettbanen deg Internet yettḍurru izerfan-nsen ddaw usaḍuf n umeskar n yizerfan n wemdan n Marikan. ']
['Ma tumneḍ s wul yelhan belli kra n taɣult neɣ taɣawsa yettwafken deg unermes-nneɣ neɣ deg yiqeddacen-nneɣ tegzem azref-ik n uḥraz, tzemreḍ (neɣ amsedday-ik) ad aɣ-d-tazneḍ izen akken ad nessuter asuffeɣ n taɣult neɣ n taɣawsa-nni, neɣ ad nessader tuqqna ɣer-s. ']
['Isental yessefk ad ttwazen s tira s yimayl (ẓer asebter "Contact" i tansa n yimayl).']
['DMCA teḥwaǧ isalli-inek n tukksa n yizerfan yettwanekṛen ad d-yeglu s yisallen-a: (1) asegzi n umahil yettwaḥerzen s yizerfan yettwanekṛen i d-yettwanekren; (2) asegzi n uḍris yettwanekren d yisallen ara aɣ-yeǧǧen ad d-naf uḍris-nni; (3) isallen n usiwel inek, ladɣa tansa-inek, uṭṭun n tilifun d tansa imayl; (4) awal sɣur-k d akken tumneḍ s wayen yelhan belli aḍris-nni s wamek i d-tettcetkiḍ ur yettwasemres ara sɣur bab n yizerfan, neɣ amesten-is, neɣ s useqdec n kra n usaḍuf; ']
['(5) yiwet n tseddi sɣur-k, yettwatten s uḥasef n lekdeb, d akken isallen yellan deg uzenzi d iṣeḥḥan u tesεiḍ azref ad tesseḍruḍ izerfan umeskar i d-yeqqaren ttwarẓen; ']
['akked (6) azmul n tfekka neɣ n tuqqna tagensit n bab n yizerfan neɣ n umdan yettwafernen ad yexdem s yisem n bab n yizerfan. ']
['Ma ur d-terriḍ ara isallen-agi akk, yezmer ad d-yeglu s uεeṭṭel deg usefrek n ucetki-inek.']
['Assaɣ']
['Ttxil-k azen-aɣ-d imayl ma tesεiḍ asteqsi / asumer.']
What is prognosis of diabetes?
The prognosis of diabetes varies depending on the type of diabetes and how well it is managed.
Type 1 diabetes is an autoimmune disease where the body does not produce insulin, and it requires lifelong insulin therapy.
With proper management, including insulin injections, healthy diet, and regular exercise, individuals with type 1 diabetes can lead long and healthy lives.
However, if not managed properly, it can lead to complications such as heart disease, kidney disease, nerve damage, and eye problems.
Type 2 diabetes is caused by insulin resistance and is often associated with lifestyle factors such as obesity and lack of physical activity.
With proper management, including medication, diet, and exercise, individuals with type 2 diabetes can improve their blood sugar control and reduce the risk of complications.
In some cases, type 2 diabetes can even be reversed through significant weight loss and lifestyle changes.
Gestational diabetes occurs during pregnancy and usually resolves after delivery.
However, women with gestational diabetes have an increased risk of developing type 2 diabetes later in life.
Overall, the prognosis for diabetes is good if it is managed properly, but it is important to work closely with a healthcare team to monitor blood sugar levels and make necessary lifestyle changes to prevent complications.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Ɣef']
['BioMedLib yesseqdac iselkimen imseddayen (algoritmes n ulmad n tnaεurt) i usnulfu n tuqqniwin n tuttriwin d tririyin.']
['Nebda s 35 imelyan n teẓrigin n tesnujjya tameddurt n PubMed/Medline. Rnu daɣen, isebtar n web n RefinedWeb.']